Pfizer plans to acquire Agila Specialties: reports

India Infoline News Service | Mumbai | ,

Reports stated that the deal could be reached this quarter.

Pfizer Inc is planning to acquire India's Agila Specialties, the injectable-medicines unit of Indian drug supplier Strides Arcolab Ltd, for a possible price of $2 bn, according to reports.

Reports stated that the deal could be reached this quarter.

Agila makes cancer treatments and antibiotics.

 

Advertisements

  • Get your free IIFL Demat & Trading A/c now...Click here
  • Get the most detailed result analysis on the web - Real Fast!
  • Actionable & Award-Winning Research on 500 Listed Indian Companies.